The recent widespread detection of counterfeit medicines across Indian states has prompted regulatory officers to demand immediate and stringent measures to safeguard public health and restore faith in the pharmaceutical supply chain.
To tackle this escalating threat from counterfeit drug networks, regulators are now proposing a specialized Enforcement Task Force. This innovative force would be led by a senior IPS officer and staffed by technologically adept young drug inspectors, combining seasoned leadership with modern expertise.